Jun 15Dag Nesse appointed as Director of Clinical OperationsREYKJAVIK, ICELAND – 15 June 2022 – EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), the clinical-stage biopharmaceutical company...
May 18Successful completion of Phase I Study for lead asset EP395· First non-antibiotic macrolide to go into clinical development – targeting COPD · Safety, tolerability and pharmacokinetic...
May 9Dr Isaac Cohen and Dr Eugen Steiner appointed to EpiEndo’s Board of DirectorsREYKJAVIK, ICELAND – 9 May 2022 – EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), the clinical-stage biopharmaceutical company...
Apr 21EpiEndo expands operations with new facility in Sweden’s largest life science clusterGrows team across Sweden, Denmark, Iceland, and the UK REYKJAVIK, ICELAND – 21 April 2022 – EpiEndo Pharmaceuticals (‘EpiEndo’), the...
Mar 24EpiEndo Pharmaceuticals expands its leadership team, appointing Stefan Petursson as CFOREYKJAVIK, ICELAND – 24 March 2022 – EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief...
Feb 14EpiEndo - A Nordic star on a Global mission! In the January edition of the Nordic Life Science Magazine (www.nordiclifescience.org), the leading life science business magazine in the...
Jan 10We are looking for a biology technician at EpiEndo Pharmaceuticals, is that you? EpiEndo Pharmaceuticals is an Icelandic clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as...
Jan 10We are looking for a biologist at EpiEndo Pharmaceuticals, is that you? EpiEndo Pharmaceuticals is a clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as a common...
Dec 13, 2021We are looking for a Director Clinical Operations at EpiEndo Pharmaceuticals, is that you?EpiEndo is a clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as a common mechanism of many...
Oct 25, 2021EpiEndo Pharma wins the Swedish American Life Science Summit (SALSS) Rising Star Award 2021EpiEndo Pharma receives the Swedish American Life Sciences Summit (SALSS) Rising Star Award 2021 for its innovation and potential impact in
Aug 18, 2021EpiEndo Secures €20 Million Series A Funding EpiEndo Pharmaceuticals Secures €20M Series A Funding to Advance Clinical Development of its Lead Compound EP395 for the Treatment of COPD
Jun 2, 2021EpiEndo Wins #1 Place in Biotech & Pharmaceuticals, at the European Innovation Council Investor Day EpiEndo is announced as the winner of the Biotech & Pharmaceuticals category, at the European Innovation Council Investor Day on Health 2021
Apr 15, 2021EpiEndo Announces €2.7 million Investment by the European Innovation Council (EIC) FundEpiEndo Pharma is the recipient of a €2.7 million convertible loan from the European Innovation Council (EIC) Fund.
Apr 13, 2021EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of Lead Candidate EP395First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the Medicines...
Apr 6, 2021EpiEndo Pharma announces the Appointment of Sigriður Valgeirsdóttir and Robert HelgasonEpiEndo Pharmaceuticals is pleased to announce the appointment of Dr. Sigríður Valgeirsdóttir and Robert Helgason to the Company’s Board
Mar 5, 2021EpiEndo and AlveoliX Receive Eurostar Grant EpiEndo Pharmaceuticals is pleased to announce that their consortium project EPIcoliX has been officially recognized as a Eurostar...
Mar 2, 2021EpiEndo Pharma Builds Science and Medical Leadership with Appointment of New CSO & CMOEpiEndo Pharma Builds Science and Medical Leadership with Appointment of New CSO & CMO
Feb 24, 2021EpiEndo Pharmaceuticals Appoints Maria Bech as New CEO to Support Move into Clinical DevelopmentREYKJAVIK, ICELAND – 24 February 2021 – EpiEndo Pharmaceuticals (www.epiendo.com) The Board of EpiEndo Pharmaceuticals is pleased to...
Jan 5, 2021EpiEndo Receives CTA Approval from UK MHRA for First-in-Man Trials of Lead Compound EP395REYKJAVIK, ICELAND - 5 January 2021 - EpiEndo Pharmaceuticals (www.epiendo.com) announced today that the Company has received approval...
Sep 21, 2020Azithromycin Protects Against SO2 Induced Lung InjuryREYKJAVIK, ICELAND – 21 September 2020 – EpiEndo Pharmaceuticals (www.epiendo.com) is pleased to share important findings in a poster at...